Cancer Immunology, Immunotherapy (submitted in 2014) Christian Krug et al.

Size: px
Start display at page:

Download "Cancer Immunology, Immunotherapy (submitted in 2014) Christian Krug et al."

Transcription

1 Cancer Immunlgy, Immuntherapy (submitted in 2014) Christian Krug et al. PBMC day 0 d 0 n anti-cd3 side scatter d 0 with anti-cd3 frward scatter PBMC day 10 d 10 n anti-cd3 side scatter d 10 with anti-cd3 frward scatter Supplementary figure 1: agnistic anti-cd3 n PBMC PBMC frm healthy dnrs were expanded fr ten days using the agnistic anti-cd3 antibdy OKT3 and IL-2. Cells, which were cultured withut the anti-cd3 antibdy, served as cntrl. PBMC were stained fr the murine anti-cd3 antibdy with a flurescence-labeled antibdy targeted against murine immunglbulin n day 0 and day 10 f culture. One representative f three experiments is depicted.

2 35 T2.A1 fresh 35 KATO III fresh relative lysis relative lysis CD3 CEA CD3 cn :1 20:1 6:1 2:1 effectr:target rati :1 20:1 6:1 2:1 effectr:target rati 35 T2.A1 thaw 35 KATO III thaw relative lysis relative lysis :1 20:1 6:1 2:1 effectr:target rati :1 20:1 6:1 2:1 effectr:target rati Supplementary figure 2: CAR-RNA-transfected T cells f healthy dnrs lyse antigen-bearing tumr cells PBMC frm healthy dnrs were expanded fr ten days using the agnistic anti-cd3 antibdy OKT3 and IL-2. The amplified T cells were electrprated with mrna encding a CEA-specific chimeric antigen receptr (CAR) r a CAR f irrelevant specificity (cn.). Cells were either used 6 h after electrpratin r crycnserved 2 h after electrpratin. Fresh and thawed T cells were assayed fr cytlytic activity in a standard 4 h chrmium 51 release assay, with T2.A1 (CEA - ) and KATO III (CEA + ) as target cells at the indicated ratis. The release f chrmium int the supernatant was determined and lysis was calculated. Mean values frm three independent experiments are depicted. Errr bars indicate standard errr f the mean.

3 Supplementary standard perating prcedure (SOP) 1: Expansin f T cells frm PBMC Equipment: cell centrifuge (e.g. Heraeus Multifuge 3 S-R; Cat.N ) tw cell culture incubatrs (e.g. Heraeus BBD 6220 CO2 Incubatr Cat.N ) vacuum pump and suctin system (e.g. Carl Rth bivac 106; Cat.N. KH49.1) Pipetby (e.g. Eppendrf easypet 3; Cat.N ) Cnsumables: X-viv 15 with Gentamycin and Phenl red (Lnza; Cat. N. BE04-418F) Prleukin IL-2, 18 x 10 6 IU / ml (Nvartis; ATC-cde L03AC01) Orthclne OKT-3, 1 g/l (Jannsen-Cilag; ATC-Cde L04AA02) cell factries (e.g. Nunc; Mat.n ) cell culture flasks T175, 600 ml (e.g. Nunc ) 50 ml cell culture tubes (e.g. Crning; Mat.N ) serlgical pipettes 5 ml (e.g. Crning; Mat.N. 4051) 10 ml (e.g. Crning; Mat.N. 4101) 25 ml (e.g. Crning; Mat.N. 4251) 50 ml (e.g. Crning; Mat.N. 4501) pipettes µl (e.g. Eppendrf Refence 2; Cat.N ) µl (e.g. Eppendrf Refence 2; Cat.N ) pipette filter tips 100 µl (e.g. Greiner filtertip 100 µl; Cat.N ) 1000 µl (e.g. MbP; Mat.N. 2079GIW) General remarks: all wrk n the pen prduct is perfrmed in a clean rm grade A (accrding t EU GMP classificatin) standard rm temperature: C; standard incubatr cnditins: 37 C; 5% CO 2 ; 95% relative humidity

4 C-applicable dcuments: SOP: generatin f peripheral bld mnnuclear cells (PBMC) SOP: determinatin f cell cncentratin SOP: FACS analyses f T cells SOP: electrpratin f T cells Starting material: peripheral bld mnnuclear cells (PBMC; 2 x 10 8 t 6 x 10 8 cells in 200 ml t 1000 ml) number f PBMC: x 10 6 vlume f PBMC: ml gently mix PBMC remve samples fr quality cntrl (with backup) 2 x 2 ml: sterility 2 x 1 ml: endtxin 2 x 1 ml: FACS-analysis fr expressin f CD3 (fr infrmatin nly) transfer all PBMC t 50 ml cell culture tubes; fill each tube with 50 ml cell suspensin transfer remains t an additinal 50 ml tube number f tubes: centrifuge tubes with settings as fllws: 10 minutes, rm temperature; 215 g; acceleratin: 9; deceleratin: 9 aspirate and discard supernatant resuspend each pellet in 5 ml X-viv 15 medium pl resuspended PBMC in T175 flask adjust cells t a cncentratin f 1.0x10 6 cells/ml with X-viv 15 medium: final cell vlume = Number f PBMC / 10 6 x ml = ml added vlume X-viv 15: ml - ( x 5 ml) = ml final cell vlume number f tubes add calculated vlume f X-viv 15 add a final cncentratin f 0.1 µg/ml Orthclne OKT-3 and 1.0x10 3 IU/ml IL-2 vlume Orthclne: ml / = 0.0 ml = µl final cell vlume add calculated vlume f Orthclne vlume IL-2: ml / = 0.0 ml = µl final cell vlume add calculated vlume f IL-2 mix cells thrughly but gently by inverting transfer cell suspensin t ne (vlume < 400 ml) r equally t 2 cell factries

5 vlume per cell factry: ml incubate cells at standard cnditins fr hurs start f incubatin: date:.. ; time: : end f incubatin: date:.. ; time: : length f incubatin: h add fresh IL-2 at a final cncentratin f 1.0x10 3 IU/ml vlume IL-2: ml / = 0.0 ml = µl vlume per cell factry add calculated vlume f IL-2 incubate cells at standard cnditins fr hurs start f incubatin: date:.. ; time: : end f incubatin: date:.. ; time: : length f incubatin: h transfer all cells t T175 flask resuspend cells remve cunting sample cunt cells accrding t SOP: determinatin f cell cncentratin cell cncentratin:. x 10 6 cells / ml cell cncentratin >= 2x10 5 cells/ml? n: abrt prductin yes: cntinue prtcl calculate ttal number f cells: ttal number f cells: ml x. x 10 6 cells / ml =. x 10 6 cell vlume cell cncentratin if ttal cell number is > 4.8 x 10 8 use 4 x 10 7 cells per factry, prepare 12 factries, discard excess: calculate cell vlume per factry: cell vlume per factry: 4 x 10 7 /. x 10 6 / ml = ml cell cncentratin transfer calculated cell vlume t factries adjust cell cncentratin t 2 x 10 5 / ml by adding X-viv 15 ad 200 ml per factry vlume X-viv 15: 200 ml - ml = ml cell vlume per factry

6 add calculated vlume f X-viv 15 add 11 µl IL-2 per factry if ttal number f cells is < 4.8 x 10 8 then divide cells int 1 t 12 cell factries: calculate number f cell factries (rund up): x 10 6 / 40 x 10 6 =. ~ cell factries ttal number f cells rund up calculate number f cells and vlume per factry: number f cells per factry: x 10 6 / = x 10 6 ttal number f cells number f factries vlume f cells per factry: ml / = ml ttal vlume f cells number f factries mix cells thrughly but gently by inverting transfer calculated vlume f cells t cell factries: adjust cell cncentratin t 2 x 10 5 cells per ml by adding X-viv 15: calculate ttal vlume per factry: ttal vlume per factry: x 10 6 / 0.2 x 10 6 = ml number f cells per factry X-viv 15 per factry: 200 ml - ml = ml vlume f cells per factry add fresh IL-2 at a final cncentratin f 1.0x10 3 IU/ml: vlume IL-2: ml / = 0.0 ml = µl ttal vlume per cell factry add calculated vlume f IL-2 incubate cells at standard cnditins fr hurs start f incubatin: date:.. ; time: : end f incubatin: date:.. ; time: : length f incubatin: h add same vlume f fresh IL-2 as calculated abve incubate cells at standard cnditins fr hurs start f incubatin: date:.. ; time: : end f incubatin: date:.. ; time: : length f incubatin: h

7 duble culture vlume by adding X-viv 15 (same vlume as ttal cell vlume per factry: vlume X-viv 15 added per factry: ml calculate new ttal vlume per factry: ml x 2 = ml vlume added add fresh IL-2 at a final cncentratin f 1.0x10 3 IU/ml: vlume IL-2: ml / = 0.0 ml = µl ttal vlume per cell factry add calculated vlume f IL-2 Incubate cells at standard cnditins fr hurs start f incubatin: date:.. ; time: : end f incubatin: date:.. ; time: : length f incubatin: h transfer all cells t 50 ml cell culture tubes; fill each tube with 50 ml cell suspensin transfer remains t an additinal 50 ml tube number f tubes: centrifuge tubes with settings as fllws: 10 minutes, rm temperature; 215 g; acceleratin: 9; deceleratin: 9 aspirate and discard supernatant resuspend each pellet in 5 ml X-viv 15 medium pl resuspended cells in T175 flask remve samples fr quality cntrl (with backup) 2 x 2 ml: sterility 2 x 1 ml: FACS-analysis f T cells resuspend cells remve cunting sample cunt cells accrding t SOP: determinatin f cell cncentratin cell cncentratin:. x 10 6 cells / ml calculate ttal number f cells: ttal number f cells:. x 10 6 cells / ml x 5 x = x 10 6 cell cncentratin number f tubes

8 Supplementary standard perating prcedure (SOP) 2: Electrpratin f activated T cells Equipment: cell centrifuge (e.g. Heraeus Multifuge 3 S-R; Cat.N ) tw cell culture incubatrs (e.g. Heraeus BBD 6220 CO2 Incubatr Cat.N ) vacuum pump and suctin system (e.g. Carl Rth bivac 106; Cat.N. KH49.1) Pipetby (e.g. Eppendrf easypet 3; Cat.N ) electrpratin device (e.g. Bi-Rad Gene Pulser Xcell, Eukarytic System; Mat.N ) refrigeratr 4 C 8 C Cnsumables: X-viv 15 with Gentamycin and Phenl red (Lnza; Cat. N. BE04-418F) RPMI 1640 (e.g. Lnza; Mat.N. BE F) OptiMEM withut phenl red (e.g. Invitrgen-Gibc; Mat.N ) Prleukin IL-2, 18 x 10 6 IU / ml (Nvartis; ATC-cde L03AC01) Orthclne OKT-3, 1 g/l (Jannsen-Cilag; ATC-Cde L04AA02) cell culture flasks T75, 200 ml (e.g. Nunc ) 50 ml cell culture tubes (e.g. Crning; Mat.N ) serlgical pipettes 5 ml (e.g. Crning; Mat.N. 4051) 10 ml (e.g. Crning; Mat.N. 4101) 25 ml (e.g. Crning; Mat.N. 4251) 50 ml (e.g. Crning; Mat.N. 4501) pipettes µl (e.g. Eppendrf Refence 2; Cat.N ) µl (e.g. Eppendrf Refence 2; Cat.N ) pipette filter tips 100 µl (e.g. Greiner filtertip 100 µl; Cat.N ) 1000 µl (e.g. MbP; Mat.N. 2079GIW) fine tip Pasteur pipette, 3 ml (e.g. VWR Cat. N )

9 electrpratin cuvettes (e.g. Peqlab; Mat.N ) CAR-mRNA in water, 1.5 µg/µl, aliquts à 90 µg, API-grade T cells generated accrding t SOP expansin f T cells frm PBMC General remarks: all wrk n the pen prduct is perfrmed in a clean rm grade A (accrding t EU GMP classificatin) standard rm temperature: C; standard incubatr cnditins: 37 C; 5% CO 2 ; 95% relative humidity C-applicable dcuments: SOP: expansin f T cells frm PBMC SOP: crycnservatin f T cells SOP: determinatin f cell cncentratin SOP: FACS analyses f T cells Starting material: T cells generated accrding t SOP expansin f T cells frm PBMC number f T cells: x 10 6 vlume f T cells: ml cncentratin f T cells: x 10 6 / ml Preparative wrk: remve RPMI 1640, OptiMEM, and X-viv 15 frm refrigeratr at least 30 min befre starting, t allw fr pre-warming t rm temperature time: : adjust electrpratin device t prtcl: square wave pulse prtcl: 500 V; 5 ms; 1 pulse; 4 mm gap cuvettes perfrm test pulse withut cuvette, nte vltage and drp: Vltage: V drp: % calculate number f cuvettes: if number f T cells is > 2.7 x 10 9 use 30 cuvettes if number f T cells is < 2.7 x 10 9 calculate number f cuvettes:

10 calculate number f cuvettes (rund up): x 10 6 / 90 x 10 6 =. ~ cuvettes number f T cells rund up transfer CAR-mRNA (ne aliqut per cuvette) frm deep freezer t refrigeratr t allw t thaw prepare T75 cell culture flasks in same number as cuvettes transfer 30 ml f X-viv 15 t each flask time at start f wrk: : if ttal cell number is < 2.7 x 10 9 use all cells, transfer all cells t 50 ml cell culture tubes; fill each tube with a maximum f 50 ml cell suspensin number f tubes: if ttal cell number is > 2.7 x 10 9 use a maximum f 2.7 x 10 9 cells calculate vlume cntaining 2.7 x 10 9 cells: vlume t be used: 2,700 x 10 6 / x 10 6 / ml = ml cncentratin f T cells gently but thrughly mix T cells by inverting transfer calculated vlume f cells t 50 ml cell culture tubes; fill each tube with a maximum f 50 ml cell suspensin number f tubes: discard rest f cells r crycnserve fr F&E accrding t SOP crycnservatin f T cells centrifuge tubes with settings as fllws: 10 minutes, rm temperature; 215 g; acceleratin: 9; deceleratin: 9 aspirate and discard supernatant resuspend each pellet in 10 ml RPMI 1640 pl cells in tw 50 ml cell culture tube centrifuge tubes with settings as fllws: 10 minutes, rm temperature; 215 xg; acceleratin: 9; deceleratin: 9 aspirate and discard supernatant resuspend each pellet in 20 ml OptiMEM pl cells in ne tube centrifuge tube with settings as fllws: 10 minutes, rm temperature; 215 xg; acceleratin: 9; deceleratin: 9 aspirate and discard supernatant calculate vlume t resuspend cells: vlume t resuspend cells: ( x 0.6 ml) ml =. ml

11 number f cuvettes add calculated vlume f OptiMEM and resuspend pellet remve CAR mrna frm refrigeratr, check if cmpletely thawed mix by tapping electrprate cells: A. transfer ne aliqut f mrna cmpletely t ne cuvette B. transfer 600 µl f cells t ne cuvette C. place cuvette in shck pd D. clse shck pd E. shck cells F. remve cuvette frm shck pd G. transfer cells frm cuvette t prepared T75 flask cntaining X-viv 15 medium with a fine tip Pasteur pipette H. repeat frm A fr all cuvettes Incubate cells at standard cnditins fr min start f incubatin: time: : end f incubatin: time: : length f incubatin: min remve samples fr quality cntrl (with backup) 2 x 2 ml: sterility 2 x 1 ml: endtxin 2 x 2 ml: FACS-analysis resuspend cells remve sample fr cunting crycnserve accrding t SOP: crycnservatin f T cells

12 Supplementary flw chart 1: Expansin f T cells frm PBMC time line X viv 15 OKT 3 IL 2 starting material: activated T cells adjust t 10 6 cells/ml in X viv 15 with 0.1 g/l OKT 3 with 1 IU/µl IL 2 QC sample: sterility, endtxin, percentage f CD3 + (FIO) day 0 IL 2 add 1 IU/µl f IL 2 day 2 QC sample: cunting yes cell cncentratin >2 x 10 5 / ml? n day 3 X viv 15 adjust t 2 x 10 5 cells / ml Abrt prductin IL 2 add 1 IU/µl f IL 2 day 5 X viv 15 IL 2 duble cell vlume with X viv 15 add 1 IU/µl f IL 2 day 7 Prduct: expanded T cells QC sample: cunting sterility, endtxin, FACS day 10 SOP: electrpratin f expanded T cells

13 Supplementary flw chart 2: Electrpratin f expanded T cells frm PBMC starting material: expanded T cells yes number f cell <2.7 x 10 9 n use all cells use 2.7 x 10 9 cells crycnserve excess crycnserved expanded T cells RPMI 1640 wash cells with RPMI 1640 OptiMEM wash cell with OptiMEM OptiMEM resuspend cells in OptiMEM at 1.5x10 8 /ml CAR mrna add 90 µg f mrna t each cuvette add 9x10 7 cells t each cuvette electrprate: 500 V, 5 ms, square wave pulse X viv 15 transfer cells t X viv 15 incubate cells fr min Prduct: CAR electrprated T cells QC sample: sterility, endtxin, FACS cunting SOP: crycnservatin f T cells

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent Prtcl Preparatin Prtcl fr the Nn-Targeted Vev MicrMarker Cntrast Agent System Cmpatibility: This guide cntains instructins and suggestins fr wrk n the Vev2100, VevLAZR, Vev 3100 systems and transducers

More information

ABIOpure TM Total RNA (version 2.0)

ABIOpure TM Total RNA (version 2.0) ABIOpure TM Ttal RNA (versin 2.0) Bld Extractin Handbk Cat N: M541RP50-B FOR RESEARCH USE ONLY Table f Cntents Cntents Page Kit Cmpnents 3 Precautins 3 Stability & Strage 4 General Descriptin 4 Limitatins

More information

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided

More information

For Research Use Only Ver

For Research Use Only Ver INSTRUCTION MANUAL Quick-cfRNA Serum & Plasma Kit Catalg N. R1059 Highlights High-quality cell-free RNA is easily and rbustly purified frm up t 3 ml f plasma, serum, r ther bilgical fluids. Purified cell-free

More information

Triglyceride Assay Kit 100 point assay kit Cat# TG-1-NC

Triglyceride Assay Kit 100 point assay kit Cat# TG-1-NC Triglyceride Assay Kit 100 point assay kit Cat# TG-1-NC INSTRUCTIN MANUAL ZBM0013.06 STRAGE CNDITINS Reagents A & B, Buffers: Store at 2-8 C. Use reconstituted Glycerol Reagent A within 7 days. Glycerol

More information

SQA-VISION VALIDATION REPORT

SQA-VISION VALIDATION REPORT Objective SQA-VISION VALIDATION REPORT T test the new cnvenience features f the SQA-Visin vs. the SQA-V and manual semen assessment: Swim-up Density Gradient Lngevity Vitality Mrphlgy Cunter Scanning Debris/Rund

More information

Materials Dissecting pan, dissecting kit, safety glasses, lab apron, pig heart, & gloves

Materials Dissecting pan, dissecting kit, safety glasses, lab apron, pig heart, & gloves Heart Dissectin Intrductin Mammals have fur-chambered hearts and duble circulatin. The heart f a bird r mammal has tw atria and tw cmpletely separated ventricles. The dublelp circulatin is similar t amphibians

More information

Midi Plant Genomic DNA Purification Kit

Midi Plant Genomic DNA Purification Kit Midi Plant Genomic DNA Purification Kit Cat #:DP022MD/ DP022MD-50 Size:10/50 reactions Store at RT For research use only 1 Description: The Midi Plant Genomic DNA Purification Kit provides a rapid, simple

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

Record of Revisions to Patient Tracking Spreadsheet Template

Record of Revisions to Patient Tracking Spreadsheet Template Recrd f Revisins t Patient Tracking Spreadsheet Template Belw is a recrd f revisins made by the AIMS Center t the Patient Tracking Spreadsheet Template. The purpse f this dcument is t infrm spreadsheet

More information

Methodology for the Extraction of Plasmodium Protein. Learning Objectives:

Methodology for the Extraction of Plasmodium Protein. Learning Objectives: Proteomics Extraction of Plasmodium Protein Methodology for the Extraction of Plasmodium Protein Extraction of entire protein from the sample requires an optimized protocol and many protocols have been

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

Extended G/L Segment Codes

Extended G/L Segment Codes Extended G/L Segment Cdes Cpy Segment Cdes t ther Sage 300 cmpanies Extended G/L Segment Cdes Extended G/L Segment Cdes is an enhanced replacement fr the Sage G/L Segment Cdes screen. It lets yu cpy segment

More information

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY 1.0 SCOPE AND APPLICATION 1.1 Methd 8032 is used t determine trace amunts f acrylamide mnmer in aqueus matrices. This methd may be applicable t ther matrices.

More information

Transfection of Sf9 cells with recombinant Bacmid DNA

Transfection of Sf9 cells with recombinant Bacmid DNA Transposition Bacmid DNA Mini Culturing baculo cells Transfection of Sf9 cells with recombinant Bacmid DNA Amplification of the virus Titration of baculo stocks Testing the expression Transposition 1.

More information

Cnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level

More information

Standard Operation Procedure (SOP) for Biobanking Sampling Procedure Manual Use

Standard Operation Procedure (SOP) for Biobanking Sampling Procedure Manual Use Standard Operation Procedure (SOP) for Biobanking Sampling Procedure Manual Use 1. Plasma, Serum and PAXgene Blood Collection 1.1. Equipment and reagents to be supplied by user 1.1.1. For blood withdrawal

More information

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION PROTOCOL SOD2 Prtein Quantity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS746 Rev.0 DESCRIPTION SOD2 Prtein Quantity Micrplate Assay Kit Sufficient materials are prvided fr

More information

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication: Schl Medicatin Authrizatin Frm Student's Name Address Birth Date Hme Phne Schl Grade Teacher Emergency Phne N: T be cmpleted by the student's physician: Name f Medicatin: Dsage Frequency Time t be given

More information

Title: Column Chromatography of Green Fluorescent Protein

Title: Column Chromatography of Green Fluorescent Protein Title: Column Chromatography of Green Fluorescent Protein Approvals: Preparer Date_07Oct06 Reviewer: Mary Jane Kurtz Date 09Jul13 Part I Crude Isolation of GFP from Lysed Cells q Page 1 of 6 1. Purpose:

More information

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution Instructins fr Use INTRON A (In-trn-aye) (Interfern alfa-2b, recmbinant) Pwder fr Slutin Be sure that yu read, understand, and fllw these instructins befre injecting INTRON A. Yur healthcare prvider shuld

More information

Module 3. Chapter 5 Microbial Metabolism. Catabolic and Anabolic Reactions Metabolism Two general types of metabolic reactions: o :

Module 3. Chapter 5 Microbial Metabolism. Catabolic and Anabolic Reactions Metabolism Two general types of metabolic reactions: o : Mdule 3 Chapter 5 Micrbial Metablism Catablic and Anablic Reactins Metablism Tw general types f metablic reactins: : : Recall frm Chapter 2: Energy can be when bnds Energy can be when bnds Catablism Purpse

More information

For research or further manufacturing use only. Not for injection or diagnostic procedures.

For research or further manufacturing use only. Not for injection or diagnostic procedures. PRIME-XV T cell Expansion XSFM PRIME-XV T Cell Expansion XSFM is a xeno-free, serum-free medium optimized for the activation and expansion of human T lymphocytes. This medium contains gentamicin and requires

More information

Rapid antigen-specific T cell enrichment (Rapid ARTE)

Rapid antigen-specific T cell enrichment (Rapid ARTE) Direct ex vivo characterization of human antigen-specific CD154+CD4+ T cell Rapid antigen-specific T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central role

More information

Medicare Quarterly Update Instructions

Medicare Quarterly Update Instructions Medicare Quarterly Update Instructins Admin Screen RBRVS Prfile Under Admin Prfessinal Calc Engine Management, select RBRVS Prfile. Click Add t add a new RBRVS Prfile Fastlad the apprpriate file frm www.advisry.cm

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice

More information

Coding. Training Guide

Coding. Training Guide Cding (Specialty Hspital) Visin 4.3 (January 2013) Training Guide SurceMedical VisinSH Cding Learning Center f Excellence Last change made: January 2013 2013 Surce Medical Slutins, Inc. All Rights Reserved.

More information

REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE

REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN February 12, 2018 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap): XVIVO HIGHLIGHTS

More information

Human ipsc-derived Microglial Precursors

Human ipsc-derived Microglial Precursors Human ipsc-derived Microglial Precursors Product Information Catalog. No. Product Name Format Storage on Arrival ax1666 Human ipsc-derived Microglial Precursors 3 x 10 6 viable cells Transfer cells to

More information

Active elbow motion is when your own muscles move the elbow back and forth.

Active elbow motion is when your own muscles move the elbow back and forth. Initial Pstperative Shulder Care and Exercise: **Can be dne if a biceps tendesis has been perfrmed. If a biceps tendesis prcedure has been perfrmed, active elbw mtin is delayed up t 6 weeks. Please clarify

More information

Instruction Manual IC ACCESS CONTROL

Instruction Manual IC ACCESS CONTROL Instructin Manual IC ACCESS CONTROL Mde: DH16A-12CT Metal surface and keypads Un-netwrked Mde: DH16A-12CTQ Metal surface and keypads Netwrked Mde: DH16A-50CT/CTN Metal surface and keypads Un-netwrked Mde:

More information

FOCUS SubCell. For the Enrichment of Subcellular Fractions. (Cat. # ) think proteins! think G-Biosciences

FOCUS SubCell. For the Enrichment of Subcellular Fractions. (Cat. # ) think proteins! think G-Biosciences 169PR 01 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name FOCUS SubCell For the Enrichment of Subcellular Fractions (Cat. # 786 260) think

More information

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs A Plasma Humral Factr f Extrarenal Origin Causing Release f Reninlike Activity in Hyptensive Dgs By E. De Vit, C. Wilsn, R. E. Shipley, R. P. Miller, and B. L. Mrtx ABSTRACT Plasma reninlike activity significantly

More information

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injectin, fr Subcutaneus Use Single-Dse Prefilled Syringe 150 mg Read this Instructins fr Use befre yu start using ZINBRYTA and each time yu get

More information

The Cannabis Act and Regulations

The Cannabis Act and Regulations The and Regulatins OVERVIEW The and Regulatins cme int frce n Octber 17, 2018 and replaces the Access t Cannabis fr Medical Purpses Regulatins (ACMPR), and any mentin f Cannabis and Marihuana in the Narctics

More information

Name: Date: Period: Notes: The Blood and Lymphatic System

Name: Date: Period: Notes: The Blood and Lymphatic System Name: Date: Perid: Cmpsitin f Bld and their Functins Red Bld Cells (aka ) Structure Ntes: The Bld and Lymphatic System D nt have a like ther cells d Cntain a specialized prtein called Hemglbin cntains

More information

Striatal Neuron Medium Kit

Striatal Neuron Medium Kit Striatal Neuron Medium Kit Product Information What are included in the Striatal Neuron Medium Kit (ax0333): 2x 250 ml Striatal Neuron Basal Medium (Store at 4 o C upon receipt) 2x 7.5 ml Striatal Neuron

More information

Nuclear Extraction Kit

Nuclear Extraction Kit Nuclear Extraction Kit Catalog Number KA1346 50 assays Version: 07 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Principle of the Assay... 3 General Information... 4

More information

Trident Membrane Protein Extraction Kit

Trident Membrane Protein Extraction Kit Cat. No. Size Shelf life GTX16373 5/ 20 tests 12 months at the appropriate storage temperatures (see below) Contents Component Storage Amount for 5 tests Amount for 20 tests Buffer A -20 o C 2.5 ml 10

More information

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at

More information

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT. CENTRE D ETUDE & DE VALORISATION DES ALGUES 2400 Detxificatin prperties f Apple pectin frmulatin, PROPECTIN. VITAPRO FINAL REPORT PrPectin July 2015 CENTRE D ETUDE ET DE VALORISATION DES ALGUES PRESQU

More information

Recipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones)

Recipes for Media and Solution Preparation SC-ura/Glucose Agar Dishes (20mL/dish, enough for 8 clones) Protocol: 300 ml Yeast culture preparation Equipment and Reagents needed: Autoclaved toothpicks Shaker Incubator set at 30 C Incubator set at 30 C 60 mm 2 sterile petri dishes Autoclaved glass test tubes

More information

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE 2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizatins, Clinical Cascade Breakut Sessin TB/HIV EXERCISE Created by the ICPI TB/HIV Wrkstream Abut this Handut

More information

CoaguChek Outpatient Clinic: Quality Control Test Procedure. Action

CoaguChek Outpatient Clinic: Quality Control Test Procedure. Action PHSA Labratries CW Site - Pint f Care Title: CWPC_INR_0130 CaguChek Outpatient Clinic Quality Cntrl Test Prcedure CaguChek Outpatient Clinic: Quality Cntrl Test Prcedure PURPOSE: This prcedure prvides

More information

ACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man HIV Quantitative PBMC culture May 2004

ACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man HIV Quantitative PBMC culture May 2004 HIV QUANTITATIVE PBMC MICROCOCULTURE ASSAY 1 PRINCIPLE The quantitative PBMC micrococulture assay estimates the number of infectious units of HIV per million mononuclear cells (IUPM) in peripheral blood

More information

RETURN TO SPORT PROGRESSION: SOCCER

RETURN TO SPORT PROGRESSION: SOCCER 1. The athlete must pass all functinal tests and/r be cleared by sprts medicine medical prvider befre beginning Return t Sccer Prtcl. 2. Recmmend pursuing Transitinal Therapy fr return t sprt activities

More information

Original Policy Date 12:2013

Original Policy Date 12:2013 MP 5.01.18 Xlair (Omalizumab) Medical Plicy Sectin Prescriptin Drugs Issu12:2013e 4:2006 Original Plicy Date 12:2013 Last Review Status/Date Lcal plicy/12:2013 Return t Medical Plicy Index Disclaimer Our

More information

William Curtis Hines III, Ph.D.

William Curtis Hines III, Ph.D. Lentiviral Methds William Curtis Hines III, Ph.D. www.breastcancerlab.cm Prject Scientist, Life Sciences Divisin Lawrence Berkeley Natinal Labratry One Cycltrn Rad, MS 977 225A, Berkeley, CA 94720, USA

More information

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham Primary Adult Naïve CD4+ CD45RA+ Cells Prepared by: David Randolph (drdrdr@uab.edu) at University of Alabama, Birmingham Goal: To obtain large numbers of highly pure primary CD4+ CD45RO- CD25- cells from

More information

Hearing Service Fees and Fee Codes Effective: January 01, 2019

Hearing Service Fees and Fee Codes Effective: January 01, 2019 Hearing Fees and Fee Cdes Effective: January 01, 2019 The WCB will fund the fllwing hearing services fr claims accepted fr traumatic and ccupatinal nise induced hearing: Fee cde 200 - Full audilgical assessment.

More information

Lumino Firefly Luciferase Assay

Lumino Firefly Luciferase Assay G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Lumino Firefly Luciferase Assay (Cat. # 786 1267, 786 1268) think proteins! think G-Biosciences

More information

Peptide stimulation and Intracellular Cytokine Staining

Peptide stimulation and Intracellular Cytokine Staining v Peptide stimulation and Intracellular Cytokine Staining Authors A. Cosma, S. Allgayer MATERIALS Date 01-02-2007 REAGENTS: Version 1.0 - PBMCs - Culture medium - Costimulating antibodies - Peptide pools

More information

Virus Harvest AAV 15 cm 2

Virus Harvest AAV 15 cm 2 Virus Harvest AAV 15 cm 2 1) Gently scrape cells from plate in 10 ml of media, place remaining 10 ml of media in plate lid. 2) Once cells are removed from plate, wash plate by pipetting 20 ml of media

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

Creating and Linking Charge Objects

Creating and Linking Charge Objects Overview Charge bject screens are used t maintain cst accunting cdes that agencies use t break ut emplyee time based n wrk perfrmed and leave time while assigned t a specific prject(s). The charge bject

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Fee Schedule - Home Health Care- 2015

Fee Schedule - Home Health Care- 2015 Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule

More information

Protocol for Thawing Cryopreserved Hepatocytes

Protocol for Thawing Cryopreserved Hepatocytes cell and tissue-based products Protocol for Thawing Cryopreserved Hepatocytes Product Instruction The following procedure may be carried out in a biosafety containment hood to reduce the risk of contamination

More information

NPCR CLINICAL EDIT CHECKS

NPCR CLINICAL EDIT CHECKS NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t

More information

SOP History Number Date Reason for Change v1 10/10/2014 Original V2 10/10/2016 Update V3 10/10/2018 Update

SOP History Number Date Reason for Change v1 10/10/2014 Original V2 10/10/2016 Update V3 10/10/2018 Update Document Number: SASoM/METHOD/073.v3 Title: Version: Author: Lentivirus production from HEK293T cells v3 Paul Reynolds Effective from: 10/10/2018 Valid to: 09/10/2020 SOP History Number Date Reason for

More information

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents E.Z.N.A. SQ Blood DNA Kit II Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Blood Storage and DNA Yield...4 Preparing Reagents...5 100-500 μl Whole Blood Protocol...6

More information

HIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory)

HIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory) HIV Diagnstic Tests HIV Testing Algrithm at SydPath (Natinal Reference Labratry) HIV1/2 Ab/Ag Cmbi is Architect HIV- 1 Ab/Ag EIA is Genscreen Sandwich EIA 4 th Generatin HIV Ab/Ag Chemiluminescene Micr

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

Item Catalog Number Manufacturer 1,4-Dithioerythritol (1 g) D9680 Sigma-Aldrich

Item Catalog Number Manufacturer 1,4-Dithioerythritol (1 g) D9680 Sigma-Aldrich SOP: Nuclei isolation from fresh mouse tissues and DNaseI treatment Date modified: 01/12/2011 Modified by: E. Giste/ T. Canfield (UW) The following protocol describes the isolation of nuclei and subsequent

More information

XTRAKT FFPE Kit / Manual

XTRAKT FFPE Kit / Manual XTRAKT FFPE Kit / Manual For manual extraction of RNA, mirna and/or DNA from Formalin Fixed Paraffin Embedded (FFPE) tissue samples Catalog No. # XTK2.0-96 For research use only. Not intended for diagnostic

More information

Pluricyte Cardiomyocytes

Pluricyte Cardiomyocytes Pluricyte Cardiomyocytes Manual Version 2.1 / March 2018 Contents 1. Introduction 2 2. Equipment, Materials and Reagents 3 3. Methods 4 3.1 Coating of tissue culture plates 4 3.2 Thawing Pluricyte Cardiomyocytes

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

The following protocol describes the isolation of nuclei from tissue. Item. Catalog No Manufacturer

The following protocol describes the isolation of nuclei from tissue. Item. Catalog No Manufacturer SOP: Nuclei isolation from tissue and DNaseI treatment Date modified: 090923 Modified by: P. Sabo. (UW) The following protocol describes the isolation of nuclei from tissue. Ordering Information Item.

More information

Mitochondrial DNA Isolation Kit

Mitochondrial DNA Isolation Kit Mitochondrial DNA Isolation Kit Catalog Number KA0895 50 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials

More information

Daily Balancing in Maestro

Daily Balancing in Maestro Daily Balancing in Maestr Successful Daily Balancing in Maestr is based n utilizing reprts that cntain key peratinal and financial infrmatin based n yur prperty s requirements Maestr has 3 Key Daily Reprts

More information

AV-07 How to Improve Data Quality and Get Value From Your CMMS. Cecelia Adair Las Vegas Valley Water District

AV-07 How to Improve Data Quality and Get Value From Your CMMS. Cecelia Adair Las Vegas Valley Water District AV-07 Hw t Imprve Data Quality and Get Value Frm Yur CMMS Cecelia Adair Las Vegas Valley Water District Purpse Hw t get mre frm yur maintenance management system Present a methdlgy t imprve data Demnstrate

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

In vitro human regulatory T cell expansion

In vitro human regulatory T cell expansion - 1 - Human CD4 + CD25 + regulatory T cell isolation, Workflow in vitro expansion and analysis In vitro human regulatory T cell expansion Introduction Regulatory T (Treg) cells are a subpopulation of T

More information

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT DESCRIPTION. RNAzol BD is a reagent for isolation of total RNA from whole blood, plasma or serum of human

More information

ab Nuclear Extract Kit

ab Nuclear Extract Kit Version 1 Last updated 10 November 2017 ab221978 Nuclear Extract Kit For the preparation of nuclear extracts from mammalian and tissue. This product is for research use only and is not intended for diagnostic

More information

Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE)

Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE) Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central

More information

In vitro human regulatory T cell expansion

In vitro human regulatory T cell expansion - 1 - Human CD4 + CD25 + CD127 dim/- regulatory T cell Workflow isolation, in vitro expansion and analysis In vitro human regulatory T cell expansion Introduction Regulatory T (Treg) cells are a subpopulation

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

Cerebrospinal taps are also performed as a component of contrast myelography.

Cerebrospinal taps are also performed as a component of contrast myelography. Flrence JUVET Resident in internal medicine University Veterinary Hspital, UCD Belfield DUBLIN 4 flrence.juvet@ucd.ie Hw t d a CSF tap? Definitin: CSF is an ultrafiltrate f plasma that is prduced predminantly

More information

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered

More information

EMEA DICOMBurner solution EMEA DICOMBurner solution

EMEA DICOMBurner solution EMEA DICOMBurner solution The mdern PACS (Picture Archiving and Cmmunicatin System) digital revlutin appears t ffer significant savings in terms f variable csts. Nevertheless, the filmless technlgy is a real advantage if there

More information

Geneaid DNA Isolation Kit

Geneaid DNA Isolation Kit Instruction Manual Ver. 02.21.17 For Research Use Only Geneaid DNA Isolation Kit GEB100, GEB01K, GEB01K+ GEC150, GEC1.5K, GEC1.5K+ GET150, GET1.5K, GET1.5K+ GEE150, GEE1.5K, GEE1.5K+ Advantages Sample:

More information

TABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.

TABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4. TABLE OF CONTENTS... Glssary f terms 2... Cde Pad Diagram 3 Understanding the Cde Pad lights.4 Cde Pad tnes 5 Fully arming the system - ON MODE 6 Fully arming the system - Quick Arm MODE 6 Partially arming

More information

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study PONS Study Synpsis Title f the Study Subtype-Stratified Fllw-up Care Study f Breast Cancer Patients with Cmbined In Vitr and In Viv Diagnstics Plus Early Target-Oriented Interventin Gals Imprve and individualize

More information

ADVL0411 study. (temozolomide in patients with leukemia)

ADVL0411 study. (temozolomide in patients with leukemia) ADVL0411 study (temozolomide in patients with leukemia) I. Overview of study: We are interested in determining the level of MGMT activity and MRS mutations in leukemic samples (plasma and lymphoblasts)

More information

Protocol. G-LISA Rac1 Activation Assay Biochem Kit : 24 Assays (Absorbance Based) Cat. # BK128-S. cytoskeleton.com. Cytoskeleton, Inc.

Protocol. G-LISA Rac1 Activation Assay Biochem Kit : 24 Assays (Absorbance Based) Cat. # BK128-S. cytoskeleton.com. Cytoskeleton, Inc. The Protein Experts Protocol Cytoskeleton, Inc. V 8.1 G-LISA Rac1 Activation Assay Biochem Kit : 24 Assays (Absorbance Based) Cat. # BK128-S cytoskeleton.com Phone: (303) 322.2254 Fax: (303) 322.2257 Customer

More information

L6 GLUT4myc Cell Growth Protocol

L6 GLUT4myc Cell Growth Protocol L6 GLUT4myc Cell Growth Protocol Background: Parental L6 cells selected for high fusion (2, 3) were stably transfected with a rat GLUT4 cdna carrying a myc epitope (recognized by the commercially available

More information

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,

More information

Action plan: serialisation of Nordic packages focus on Product Codes

Action plan: serialisation of Nordic packages focus on Product Codes 19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in

More information

EUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008

EUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008 Eurpean Medicines Agency Dc. Ref. EMEA/522876/2008 P/84/2008 EUROPEAN MEDICINES AGENCY DECISION f 14 Octber 2008 n the applicatin fr agreement f a Paediatric Investigatin Plan fr valsartan (Divan) (EMEA-000005-PIP01-07)

More information

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Supplemental methods Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Materials PBMC isolated from patients, relatives and healthy donors as control K562 cells (ATCC,

More information

Methodology for the Extraction of Brain Tissue Protein. Learning Objectives:

Methodology for the Extraction of Brain Tissue Protein. Learning Objectives: Proteomics Extraction of Brain Tissue Protein Methodology for the Extraction of Brain Tissue Protein Extraction of the entire protein from the sample requires optimized protocol and many protocols have

More information

Yescarta (axicabtagene ciloleucel) (Intravenous)

Yescarta (axicabtagene ciloleucel) (Intravenous) Yescarta (axicabtagene cilleucel) (Intravenus) Last Review Date: 10/31/2017 Date f Origin: 10/31/2017 Dates Reviewed: 10/2017 Dcument Number: IC-0333 I. Length f Authrizatin Cverage will be prvided fr

More information

Size distribution analysis with the Nanoparticle Nebulizer Model 3485 in combination with an SMPS (spray characterisation)

Size distribution analysis with the Nanoparticle Nebulizer Model 3485 in combination with an SMPS (spray characterisation) SOP: Size distributin analysis with the Nanparticle Nebulizer Mdel 3485 in cmbinatin with an SMPS (spray characterisatin) Date 28.05.2016 Versin 1.0 English Cntent 1 Scpe 2 2 Basics Nanparticle Nebulizer

More information

Intended Use KontrolFlex Endodontic Rotary Files fit into a dental handpiece allowing the user to perform root canal debridement.

Intended Use KontrolFlex Endodontic Rotary Files fit into a dental handpiece allowing the user to perform root canal debridement. KntrlFlex Enddntic Rtary Files KntrlFlex Enddntic Rtary Files are available Nn-Sterile with varius ISO tip sizes and wrking lengths. The devices are intended t be cleaned and sterilized using steam sterilizatin

More information

Application Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood

Application Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood Application Information Bulletin: Human NK Cells Phenotypic characterizing of human Natural Killer (NK) cell populations in peripheral blood Christopher A Fraker, Ph.D., University of Miami - Miami, Florida

More information

Pandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1

Pandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1 MODIFIED HEMAGGLUTINATION INHIBITION (HI) ASSAY USING HORSE RBCS FOR SEROLOGIC DETECTION OF ANTIBODIES TO H7 SUBTYPE AVIAN INFLUENZA VIRUS IN HUMAN SERA Pandemic Preparedness Team Immunology and Pathogenesis

More information

Gladstone Institutes, University of California (UCSF), San Francisco, USA

Gladstone Institutes, University of California (UCSF), San Francisco, USA Fluorescence-linked Antigen Quantification (FLAQ) Assay for Fast Quantification of HIV-1 p24 Gag Marianne Gesner, Mekhala Maiti, Robert Grant and Marielle Cavrois * Gladstone Institutes, University of

More information